200 related articles for article (PubMed ID: 18855719)
1. Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome.
Anfossi G; Russo I; Trovati M
Curr Vasc Pharmacol; 2008 Oct; 6(4):313-28. PubMed ID: 18855719
[TBL] [Abstract][Full Text] [Related]
2. Platelet dysfunction in central obesity.
Anfossi G; Russo I; Trovati M
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):440-9. PubMed ID: 19346117
[TBL] [Abstract][Full Text] [Related]
3. The platelet in diabetes: focus on prevention of ischemic events.
Colwell JA; Nesto RW
Diabetes Care; 2003 Jul; 26(7):2181-8. PubMed ID: 12832332
[TBL] [Abstract][Full Text] [Related]
4. Utility of aspirin therapy in patients with the cardiometabolic syndrome and diabetes.
Gardner M; Palmer J; Manrique C; Lastra G; Gardner DW; Sowers JR
J Cardiometab Syndr; 2009; 4(2):96-101. PubMed ID: 19614796
[TBL] [Abstract][Full Text] [Related]
5. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
Gasparyan AY; Watson T; Lip GY
J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.
Verdoia M; Pergolini P; Nardin M; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
J Thromb Thrombolysis; 2016 Aug; 42(2):245-53. PubMed ID: 26951167
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
Santilli F; Lapenna D; La Barba S; Davì G
Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
9. Platelet function profiles in patients with diabetes mellitus.
Rollini F; Franchi F; Muñiz-Lozano A; Angiolillo DJ
J Cardiovasc Transl Res; 2013 Jun; 6(3):329-45. PubMed ID: 23404189
[TBL] [Abstract][Full Text] [Related]
10. The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines.
Hostetter JC; Bhatt DL
Minerva Cardioangiol; 2003 Oct; 51(5):531-46. PubMed ID: 14551522
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.
Capranzano P; Capodanno D
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):307-17. PubMed ID: 23469911
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy: controversial aspects.
Coccheri S
Thromb Res; 2012 Mar; 129(3):225-9. PubMed ID: 22119155
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of antiplatelet therapy.
Wiviott SD; Tantry US; Gurbel PA; ;
Rev Cardiovasc Med; 2006; 7(3):130-46; quiz 148-9. PubMed ID: 17088858
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy.
Anfossi G; Trovati M
Cardiovasc Hematol Agents Med Chem; 2006 Apr; 4(2):111-28. PubMed ID: 16611047
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of platelet activation in acute coronary syndromes.
Stakos DA; Tziakas DN; Stellos K
Curr Vasc Pharmacol; 2012 Sep; 10(5):578-88. PubMed ID: 22338573
[TBL] [Abstract][Full Text] [Related]
17. Review of aspirin and clopidogrel resistance in peripheral arterial disease.
Guirgis M; Thompson P; Jansen S
J Vasc Surg; 2017 Nov; 66(5):1576-1586. PubMed ID: 28893489
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.
Ariturk Z; Islamoglu Y; Gündüz E; Yavuz C; Cil H; Tekbas E; Soydinc S; Kaya H; Elbey MA
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):617-21. PubMed ID: 22774402
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.
Colwell JA
Am J Cardiovasc Drugs; 2004; 4(2):87-106. PubMed ID: 15049721
[TBL] [Abstract][Full Text] [Related]
20. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
